Open menu INVESTOR RELATIONS Vifor Pharma held a conference call following the announcement of the acquisition of Sanifit Therapeutics and Inositec AG. Replay 859.3 281 2.92 CHF 189.8 76.5 % 320.5 246.4 79.9 Address Vifor Pharma Management Ltd. Flughofstrasse 61 P.O. Box 8152 Glattbrugg Switzerland Stay in touch Keep up to date on social media or contact us with any other information +41 58 851 80 00 Quick Links About Vifor Pharma Therapy areas Products Investors Media Responsibility Footer Legal Notice Terms of Use Privacy Policy Cookie Policy Sign up for email alerts By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Accept All Cookies Cookies Settings

Open menu FORM 8937 Address Vifor Pharma Management Ltd. Flughofstrasse 61 P.O. Box 8152 Glattbrugg Switzerland Stay in touch Keep up to date on social media or contact us with any other information +41 58 851 80 00 Quick Links About Vifor Pharma Therapy areas Products Investors Media Responsibility Footer Legal Notice Terms of Use Privacy Policy Cookie Policy Sign up for email alerts By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Accept All Cookies Cookies Settings

Open menu HALF-YEAR REPORT 2021 Our mission is to help patients around the world with severe and chronic diseases lead better, healthier lives. On this page: Highlights Patients Portfolio Finance Responsibility Choose a PDF document based on language: English Half-year Report 2021 (PDF) 859.3 MCHF 281.0 MCHF 2.92 CHF 189.8 MCHF 76.5 % 320.5 MCHF 246.4 MCHF 79.9 MCHF Left Right / Ferinject®/Injectafer® / ESA Portfolio / Velphoro® PATIENTS 16 Million patient years of experience (approx.) FERINJECT®/INJECTAFER® 84 Countries with market approval YEAR-TO-DATE GROWTH 22.8 % Total Ferinject®/Injectafer® net sales increase (at constant exchange rates) Vifor Pharma has been a pioneer in the development of iron-based products and has established itself as a global leader in the treatment of iron deficiency and iron deficiency anemia. Address Vifor Pharma Management Ltd. Flughofstrasse 61 P.O. Box 8152 Glattbrugg Switzerland Stay in touch Keep up to date on social media or contact us with any other information +41 58 851 80 00 Quick Links About Vifor Pharma Therapy areas Products Investors Media Responsibility Footer Legal Notice Terms of Use Privacy Policy Cookie Policy Sign up for email alerts By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Accept All Cookies Cookies Settings